About Ekso Bionics Holdings Inc
Ticker
info
EKSO
Trading on
info
NASDAQ
ISIN
info
US2826444000
Industry
info
Medical Instruments & Supplies
Sector
info
Healthcare
CEO
info
Scott G. Davis
Headquarters
info
101 Glacier Point, San Rafael, CA, United States, 94901
Employees
info
61
Website
info
eksobionics.com
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Metrics
BasicAdvanced
Market cap
info
$12.2M
P/E ratio
info
-
EPS
info
-$6.49
Dividend Yield
info
0.00%
Beta
info
1.02
Forward P/E ratio
info
0
EBIDTA
info
$-10.5M
Ex dividend date
info
-
Price & volume
Market cap
info
$12.2M
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
0.84
Price to book
info
1.11
Earnings
EPS
info
-$6.49
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-10.5M
Revenues (TTM)
info
$14.7M
Revenues per share (TTM)
info
$8.52
Technicals
Beta
info
1.02
52-week High
info
$18.15
52-week Low
info
$2.73
50-day moving average
info
$3.77
200-day moving average
info
$6.06
Short ratio
info
2.1
Short %
info
5.23%
Management effectiveness
ROE (TTM)
info
-96.44%
ROA (TTM)
info
-30.17%
Profit margin
info
-75.66%
Gross profit margin
info
$7.5M
Operating margin
info
-193.24%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
-58.40%
Share stats
Outstanding Shares
info
2.6M
Float
info
2.2M
Insiders %
info
4.95%
Institutions %
info
2.75%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$6.75
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.10
-$0.10
-
Q3 • 24Beat
-$0.14
-$0.08
-75.00%
Q4 • 24Missed
-$0.12
-$0.16
25.00%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$3.4M
$-2.9M
-85.66%
Q1 • 25
$2.1M
$-2.7M
-131.70%
Q2 • 25
-39.05%
-6.30%
53.74%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$27.3M
$14.6M
53.53%
Q1 • 25
$23.2M
$12.2M
52.82%
Q2 • 25
-15.17%
-16.29%
-1.32%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-2M
$-0M
$3.5M
$-2M
Q1 • 25
$-3.4M
$-0M
$0.6M
$-3.4M
Q2 • 25
75.27%
300.00%
-82.54%
75.27%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Ekso Bionics Holdings Inc share?
Collapse

Ekso Bionics Holdings Inc shares are currently traded for undefined per share.

How many shares does Ekso Bionics Holdings Inc have?
Collapse

Ekso Bionics Holdings Inc currently has 2.6M shares.

Does Ekso Bionics Holdings Inc pay dividends?
Collapse

No, Ekso Bionics Holdings Inc doesn't pay dividends.

What is Ekso Bionics Holdings Inc 52 week high?
Collapse

Ekso Bionics Holdings Inc 52 week high is $18.15.

What is Ekso Bionics Holdings Inc 52 week low?
Collapse

Ekso Bionics Holdings Inc 52 week low is $2.73.

What is the 200-day moving average of Ekso Bionics Holdings Inc?
Collapse

Ekso Bionics Holdings Inc 200-day moving average is $6.06.

Who is Ekso Bionics Holdings Inc CEO?
Collapse

The CEO of Ekso Bionics Holdings Inc is Scott G. Davis.

How many employees Ekso Bionics Holdings Inc has?
Collapse

Ekso Bionics Holdings Inc has 61 employees.

What is the market cap of Ekso Bionics Holdings Inc?
Collapse

The market cap of Ekso Bionics Holdings Inc is $12.2M.

What is the P/E of Ekso Bionics Holdings Inc?
Collapse

The current P/E of Ekso Bionics Holdings Inc is null.

What is the EPS of Ekso Bionics Holdings Inc?
Collapse

The EPS of Ekso Bionics Holdings Inc is -$6.49.

What is the PEG Ratio of Ekso Bionics Holdings Inc?
Collapse

The PEG Ratio of Ekso Bionics Holdings Inc is 0.

What do analysts say about Ekso Bionics Holdings Inc?
Collapse

According to the analysts Ekso Bionics Holdings Inc is considered a buy.